Protocol No.: EAY191-A6

A ComboMATCH Treatment Trial: FOLFOX in Combination with Binimetinib as 2nd Line Therapy for Patients with Advanced Biliary Tract Cancers with MAPK Pathway Alterations
Principal Investigator
Boone, Brian
Phase
II
Age Group
Adult
Applicable Disease Site
Gastrointestinal Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Meg Zafiris
Research Specialist

View on ClinicalTrials.gov